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West Nile Virus (WNV), a member of the genus Flavivirus, is one of the most widely distrib-
uted arboviruses in the world. Despite some evidence for circulation of WNV in countries
summarized by the World Health Organization as the Eastern Mediterrian Regional Office
(EMRO), comprehensive knowledge about its epidemiology remains largely unknown. This
study aims to provide a concise review of the published literature on WNV infections in the
Eastern Mediterranean Regional Office of WHO (EMRO).
Methodology/principal findings
A systematic review of WNV prevalence studies on humans, animals and vectors in the
EMRO region was performed by searching: Web of Science, Science Direct, Scopus,
PubMed, Embase and Google Scholar. Finally, 77 citations were included, comprising 35
seroprevalence studies on general population (24460 individuals), 15 prevalence studies
among patients (3439 individuals), 22 seroprevalence studies among animals (10309 ani-
mals), and 9 studies on vectors (184242 vector species). Of the 22 countries in this region,
five had no data on WNV infection among different populations. These countries include
Kuwait, Bahrain, Oman, Syria and Somalia. On the other hand, among countries with avail-
able data, WNV-specific antibodies were detected in the general population of all investi-
gated countries including Djibouti (0.3–60%), Egypt (1–61%), Iran (0–30%), Iraq (11.6–
15.1%), Jordan (8%), Lebanon (0.5–1%), Libya (2.3%), Morocco (0–18.8%), Pakistan (0.6–
65.0%), Sudan (2.2–47%), and Tunisia (4.3–31.1%). WNV RNA were also detected in
patient populations of Iran (1.2%), Pakistan (33.3%), and Tunisia (5.3% –15.9%). WNV-spe-
cific antibodies were also detected in a wide range of animal species. The highest seroposi-
tivity rate was observed among equids (100% in Morocco) and dogs (96% in Morocco). The







Citation: Eybpoosh S, Fazlalipour M, Baniasadi V,
Pouriayevali MH, Sadeghi F, Ahmadi Vasmehjani A,
et al. (2019) Epidemiology of West Nile Virus in the
Eastern Mediterranean region: A systematic review.
PLoS Negl Trop Dis 13(1): e0007081. https://doi.
org/10.1371/journal.pntd.0007081
Editor: Hans-Peter Fuehrer, Vienna, AUSTRIA
Received: June 3, 2018
Accepted: December 14, 2018
Published: January 29, 2019
Copyright: © 2019 Eybpoosh et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript.
Funding: The authors received no specific funding
for this work.
Competing interests: The authors have declared
that no competing interests exist.
highest seroprevalence among birds was seen in Tunisia (23%). In addition, WNV infection
was detected in mosquitoes (Culex, and Aedes) and ticks (Argas reflexus hermanni). The
primary vector of WNV (Culex pipiens s.l.) was detected in Djibouti, Egypt, Iran and Tunisia,
and in mosquitoes of all these countries, WNV was demonstrated.
Conclusions
This first systematic regional assessment of WNV prevalence provides evidence to support
the circulation of WNV in the EMRO region as nearly all studies showed evidence of WNV
infection in human as well as animal/vector populations. These findings highlight the need
for continued prevention and control strategies and the collection of epidemiologic data for
WNV epidemic status, especially in countries that lack reliable surveillance systems.
Author summary
West Nile Virus (WNV) is a mosquito-borne Flavivirus belonging to the Flaviviridae fam-
ily, which is endemic in a vast geographical area, including the EMRO region. However,
the epidemiology of WNV in the EMRO region remains poorly understood. To address
this gap, we performed a systematic review on WNV prevalence studies conducted on
human populations, animals and vectors across Eastern Mediterranean countries. Our
review indicated the infection of most investigated human, animal and vector populations
with WNV; however, the paucity of epidemiological data underline the need for inte-
grated surveillance programs as well as continued deployment of prevention and control
strategies.
Introduction
West Nile Virus (WNV) is one of the most widely distributed arboviruses in the world, and a
pathogen of public health significance in both humans and animals [1]. This mosquito-borne
virus has been classified in the genus Flavivirus within the family Flaviviridae [2]. In nature,
WNV is maintained in a zoonotic transmission cycle between birds and mosquitos, principally
the Culex species. Susceptibility to WNV infection has also been indicated for many other ver-
tebrate hosts including mammals, birds, reptiles, and amphibians [3]. Equines and humans are
incidental “dead-end” hosts who do not play a role in the transmission cycle of the virus. How-
ever, equines and humans may manifest sever disease or death as a consequence of infection
[4]. Since the first discovery of the virus in 1937 in the West Nile district of Uganda [5], it has
undergone a substantial geographical migration, and spread around the globe. Infection with
WNV was first identified in an EMRO country (Sudan) in the 1940s. Since then, infection
with the virus has been reported in Egypt (1950s), Iran (1970s), and subsequently in several
other countries across the region [6]. The prevention and control efforts substantially rely on
effective surveillance of the infection in birds, vectors, animals, and humans. Despite several
studies on different aspects of WNV epidemiology in the EMRO region, there are still many
unknowns about the circulation of the virus and the driving factors of outbreaks [6, 7]. Under-
standing the epidemiology of WNV in the EMRO faces a number of challenges including inad-
equate knowledge of physicians about the nature of the disease, misdiagnosis of other
common infectious diseases due to similarity in clinical presentations, poor diagnostic
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infrastructures and the absence of confirmatory assays for serological tests, and lack of a com-
prehensive and progressive monitoring and surveillance system in majority of countries. The
latter has resulted in a gap in knowledge regading the prevalence of WNV infection in the
EMRO region. Therefore, we designed a systematic review to provide a clear and comprehen-
sive presentation of the virus prevalence distribution among human and animal populations
as well as infection rate in vectors of the region, based on available data.
Methods
Data sources and search strategy
Articles were screened and selected according to the PRISMA criteria [8]. The PRISMA check-
list completed for this review is presented in S1 File. We made an electronic literature search
through Web of Science, Scopus, PubMed, Google Scholar, and Index Medicus for the Eastern
Mediterranean region database (IMEMR) using different combinations of the following key-
words ‘West Nile virus, West Nile Fever, WNV’ and the name of the EMRO countries as:
Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco,
Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab
Emirates, and Yemen (S2 File). All databases were searched for English-language original arti-
cles published from database inception to January 30, 2018. Choosing multiple sources for arti-
cle search we aimed to enhance our sensitivity in finding relevant articles. To find citations
that were not indexed in our target databases, we reviewed the reference lists of relevant
articles.
Review selection
Studies identified through electronic and manual searches were listed in EndNote software
(EndNote X7, Thomson Reuters). After exclusion of duplicate citations, two authors (MF, FS)
independently reviewed titles and abstracts according to the research question. Relevant stud-
ies were obtained in full, and assessed for eligibility and risk of bias as described below. All
original articles from peer-reviewed scientific journals with a cross-sectional or survey design
that estimated the prevalence of WNV infection in humans, animals, or infection rate in vec-
tors were potentially eligible for inclusion in this review. Relevant studies whose abstract was
available but their full-text was not (even after contacting the authors via e-mail), were kept in
this review in order to present all available data. Studies from outside of the EMRO region
were excluded. Any disagreements between the review team were resolved through discussion.
Risk of bias assessment
The risk of bias in primary studies was assessed following the Cochrane approach [9]. We also
considered individual studies’ sample size (precision) as a criterion to assess risk of bias, as
proposed by Humphre, et al. [10]. Therefore, we evaluated each WNV prevalence study in
three domains: 1) sampling method, 2) response level (the proportion of subjects who accept
to participate in the study), and 3) type of assay used for the detection of WNV. Each study
was considered to have a low risk of bias if: 1) it used probability-base/random sampling meth-
ods, 2) maintained participants’ response level at�80% [11, 12], or 3) it employed viral neu-
tralization testing (VNT) for a prevalence study on the general population or used biological
tests including viral genome detection and virus isolation from infected individuals. Studies
were classified as having unclear risk of bias for a given domain if they did not provide infor-
mation for that specific domain. Use of probabilistic sampling methods was only evaluated for
studies on the general population, because acute infection studies included individuals
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attending to healthcare facilities. For studies that were conducted on blood samples collected
and stored from blood donors, response rate criteria were not evaluated. Studies on human
subjects were considered to have high precision if their sample sizes were� 100 [13]. More-
over, in the studies on WNV vectors, minimum infection rates (MIR), that were calculated for
samples of� 1000 specimens, were considered as a reliable representation of the true infection
rate in the vector population [14, 15].
Data extraction
Data was extracted from the selected studies using a researcher-made and piloted data extrac-
tion form in excel. For studies on human and animal subjects we extracted data on: first
author, year of publication, year of implementation, country, city/governorate, sample size,
participants’ age and sex (for human subjects only), animal species (for studies on animals),
assay type, and estimated assay-based WNV prevalence. For studies on vector populations, fur-
ther data was extracted including vector species, number of species (vectors) tested, collection
methods, number and size of the pools as well as the number of positive pools for each species.
WNV minimum infection rate (MIR) for each species was calculated by dividing the number
of positive pools by the total number of specimens tested for that specific species and multi-
plied by 1000. When data was available, assay-specific MIRs were calculated and reported.
Results
Search results
Database search resulted in 3298 records. After removal of duplicates, we initially screened the
title and abstract of 2667 records, 2488 of which were excluded as they were irrelevant to this
review. The remaining 179 papers were reviewed in full, of which 77 eligible reports on the
prevalence/MIR of WNV covering 17 countries in the EMRO region were included in this sys-
tematic review. We identified two relevant citations by reviewing the reference list of these rel-
evant studies [16, 17]. Fig 1 shows the literature search process. The full-text of five studies
could not be obtained even after contacting the authors [18–22]. These studies were kept in
this review to present all available data to the readers. All included studies on WNV entailed
27899 individuals (24460 general populations and 3439 patients), 10309 animals, and 184242
vector species.
Risk of bias assessment results
A summary of the risk of bias assessment results is shown in Table 1. In brief, most human
studies (28 out of 35) contained sample sizes of�100 participants, yielding a high precision in
the reported prevalence measure. Thirty out of thirty-five studies on the general population
reported their sampling strategy, fourteen of which utilized some forms of random sampling,
and hence, had low risk of bias at this domain. In most studies on the general population (24
out of 35), risk of bias assessment was affected by unclear reporting in the ‘response rate’
domain. Six studies were performed on volunteers or on blood specimens stored in national
reference laboratories or blood transfusion centers, and hence, were not subjected to risk of
bias assessment in the ‘response rate’ domain. Viral neutralization test was performed in
40.0% and 13.3% of prevalence studies on the general and patient populations, respectively,
which entails a low risk of bias for the assays used.
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Fig 1. Flow diagram of article selection for West Nile prevalence in human and animals, and infection rate in vectors of the EMRO region.
Four citations included data on more than one subject categories (i.e., humans, animal species, and vectors).
https://doi.org/10.1371/journal.pntd.0007081.g001
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Table 1. Precision and risk of bias assessment for West Nile virus prevalence measures in the EMRO region.
Author, Year Country Sampling Method¥ Risk of bias Precision Ref.
In sampling¥ In response rate In assay selection
General population
Andayi, 2014 Djibouti Random Low Unclear Low High [23]
Faulde, 2012 Djibouti Conv. Low Low (100%) High Low [24]
Youssef, 2017 Egypt Conv. High Unclear High High [25]
Soliman, 2010 Egypt Random Low Unclear Low High [26]
Darwish 1996 Egypt Unclear Unclear Unclear High High [22]
Corwin, 1993 Egypt CS Low Low (93%) High High [27]
Corwin, 1992 Egypt Random Low Low (78%) High High [28]
Darwish, 1975 Egypt CS Low Unclear High High [29]
Taylor, 1956 Egypt CS Low Unclear Low High [30]
Aghaie, 2016 Iran Conv. High Unclear High High [31]
Meshkat, 2015 Iran MSCS Low Unclear High High [32]
Chinikar, 2013 Iran Unclear Unclear Unclear High Low [33]
Sharifi, 2010 Iran Conv. High Low (100%)� High High [34]
Saidi, 1976 Iran Random Low Unclear Low High [17]
Saidi,1974 Iran Random Low Unclear NA High [16]
Naficy, 1970 Iran Unclear Unclear Unclear Low High [19]
Barakat, 2016 Iraq Conv. High Low (100%)�� Low High [35]
Batieha, 2000 Jordan Conv. High 56% High High [36]
Gallian, 2010 Lebanon Conv. High Unclear Low High [37]
Garabedian, 1971‡ Lebanon Unclear Unclear Unclear High High [18]
Shaibi, 2017 Libya Random Low Unclear High High [38]
El Harrak 2016‡ Morocco Conv. High Unclear Low High [39]
El Rhaffouli, 2013 Morocco Conv. High Low (100%)� Low High [40]
El Rhaffouli, 2012 Morocco Random Low Low (100%) Low High [41]
Niazi 2017 Pakistan Random Low Unclear High High [42]
Sugamata, 1989 Pakistan Unclear Unclear Unclear Low High [43]
Sugamata, 1988 Pakistan Unclear Unclear Unclear Low Low [44]
Darwish, 1983 Pakistan Conv. High Unclear High Low [45]
Hayes, 1982 Pakistan Conv. High Low (100%)�� Low High [46]
Yousof 2017 Sudan Random Low Low (100%)� High Low [47]
Farnon 2010 Sudan Conv. High Unclear Low Low [48]
Salim, 1973 Sudan Conv. High Unclear Low High [49]




CS Low Unclear Low High [50]
Riabi, 2010 Tunisia Conv. High Low (100%)�� Low High [51]
Alfaresi, 2008 UAE Conv. High Unclear High Low [52]
Patients
Elyan, 2014 Afghanistan NA NA Unclear High High [53]
Darwish, 1987 Egypt NA NA Unclear High Low [54]
Mohammed, 1970 Egypt NA NA Low (100%) High High [55]
Abdel Wahab, 1970‡ Egypt NA NA Unclear NA High [20]
Chinikar, 2012 Iran NA NA Unclear Low High [56]
Yaqub,2017 Pakistan NA NA Low (100%)€ Low High [57]
Khan, 2016 Pakistan NA NA 100% High High [58]
(Continued)
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WNV prevalence among the general and patient populations of the EMRO
region
A total of 50 human prevalence studies for WNV were identified, 35 of which estimated the
seroprevalence in the general population. Furthermore, and 15 of them investigated the pres-
ence of WNV antibody or genetic material in patients suspected with WNV infection. Human
studies covered 14 of 22 countries of the EMRO region, and were published from 1942 to
2017. The highest number of human studies were reported from Egypt (n = 10), Iran (n = 8),
and Pakistan (n = 9), most of which targeted the general population. ELISAs were the most
commonly used diagnostic method for the general and patient populations. Table 2 presents
detailed data for these studies. The geographic distribution of human prevalence studies is also
illustrated in Fig 2A and 2B.
Regarding the general population, WNV antibodies were detected in 11 countries including
Djibouti (n = 2, 0.3–60%), Egypt (n = 7, 1–61%), Iran (n = 6, 0–30%), Iraq (n = 1, 11.6–15.1%),
Jordan (n = 1, 8%), Lebanon (n = 2, 0–1%), Libya (n = 1, 2.3%), Morocco (n = 3, 0–18.8%),
Pakistan (n = 5, 0.2–65%), Sudan (n = 5, 2.2–47%), and Tunisia (n = 1, 4.3–31.1%). Since 2010,
seroprevalence of WNV among the general population has been investigated in Djibouti,
Egypt, Iran, Iraq, Libya, Morocco, and Sudan among which the lowest and highest median
prevalence was found in Iran (median prevalence = 1.4, range: 0–18%; total SS = 1322; 2010–
2012), and Egypt (median prevalence = 55%; total SS = 160, 2013–2014), respectively
(Table 2).
In addition, the presence of WNV antibody or genetic material in patients was investigated
in 15 human prevalence studies. In this regard, seven studies assessed WNV IgM, five of which
detected the antibodies in patients’ sera. These studies were from Afghanistan (n = 1, 0.5%),
Pakistan (n = 1, 6.6%), Sudan (n = 2, 0.3–87.5%), and Yemen (n = 1, 14.3%). Four studies [56,
59, 63, 64] used both serological and molecular assays to detect WNV IgM as well as WNV
RNA in patients’ sera (Table 2).
Table 1. (Continued)
Author, Year Country Sampling Method¥ Risk of bias Precision Ref.
In sampling¥ In response rate In assay selection
Bryan, 1996‡ Pakistan NA NA Unclear NA High [21]
Igarashi, 1994 Pakistan NA NA Unclear Low High [59]
Depoortere, 2004 Sudan NA NA Low (100%)€ High Low [60]
McCarthy, 1996 Sudan NA NA Unclear High High [61]
Watts, 1994 Sudan NA NA Unclear High High [62]
Riabi, 2014 Tunisia NA NA Unclear Low High [63]
Feki, 2005 Tunisia NA NA Low (100%) Low Low [64]
Qassem, 2014 Yemen NA NA Unclear High Low [65]
� On blood specimens stored in the blood transfusion center
�� On volunteers
‡ Studies were classified as having “Unclear” risk of bias for a given domain if they did not provide information for that specific domain. These studies were categorized
as “Unclear” risk of bias.
¥ Use of probabilistic sampling methods was only evaluated for studies on the general population, because acute infection studies included individuals attending to
healthcare facilities. So, risk of bias assessment for the “sampling” domain, was “Not Applicable” (NA) for patients.
€ On archived samples.
Abbreviations: Conv: Convenience sampling. CS: Cluster Sampling. MSCS: Multi-stage cluster sampling. NA: Not applicable to the field.
https://doi.org/10.1371/journal.pntd.0007081.t001
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Fig 2. WNV infection reported among human and animal populations of the EMRO countries. A) studies conducted between 2009 and 2017; B) studies conducted
before 2009. Black symbols indicate samples with evidence of WNV infection. The exact sampling location and the prevalence values are provided in the Tables 2 and 3.
Countries with no qualified study on human or animal populations are colored in gray. ×2: Where more than one study/sampling effort have been done on a particular
species in the same geographic area. UAE: United Arab Emirates.
https://doi.org/10.1371/journal.pntd.0007081.g002
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Country City/governorate Species SS Prevalence (%) Ref







91 - 56.5 - - - - - [66]
Durand, 2016 2012 Morocco Total Dog 231 - - 62.0 80.0
�
- - - [67]
Benslimane - - 54.0 - - -
Kenitra - - 96.0 - - -
Khenifra - - 75.0 - - -
Sidi Slimane - - 94.5 - - -
Touil, 2012 2003 Morocco Total Camel 556 - - - 10.4 - - - [68]
Guelmim (Atlantic littoral) 73 - - - 23.0 - - -
Smara (Sahara) 85 - - - 8.0 - - -
Aousserd (Sahara) 389 - - - 9.0 - - -
2009 Total 836 - - - 13.6 - - -
Oued Draa 157 - - - 12.0 - - -
Laayoune (Atlantic littoral) 397 - - - 15.0 - - -
Smara (Sahara) 282 - - - 12.0 - - -
Darwish, 1983 1983 Pakistan Karachi, Sind, Punjab Total 172 - - - - - - 9.9 [45]
Cow 45 - - - - - - 2.2
Buffalo 33 - - - - - - 15.1
Sheep 46 - - - - - - 23.9
Goat 48 - - - - - - 0
Azmi, 2017 2014 Palestine Nablus, Jericho, and Jenin Goat, Sheep 95 - - 14.7 - - - - [69]
Camel 35 - - 40.0 - - - -
Hassine, 2017 2016 Tunisia Medenine Camel 87 - - 0.0 - - - - [70]
Kebili 31 - - 25.8 - - - -
Wild animals
Marié, 2016 2016 Djibouti Djibouti Ruminants 11 - 25.3 - - - - - [66]
Darwish, 1983 1983 Pakistan Karachi Rodents 157 - - - - - - 4.5 [45]
Horses





Iran Khuzestan Province Horse 155 - - 70.3 - - - - [71]
Chinikar, 2013 2010–
2012
Iran Total Equine 315 - 2.8 - - - - - [33]
Golestan 65 - 6.1 - - - - -
Gilan 98 - 2.0 - - - - -





Iran 27 provinces of Iran Equine 1054 0.8 - - 23.6 - - - [72]
Abutarbush,
2014
2012 Jordan Irbid, Ajlun and Jerash Horse 253
-
- - 24.9 0 - - [73]
Amman and Madaba
Ma’an, Karak, Tafelah and Aqaba
Mafraq and Zarka
Jordan Valley and Balqa
Benjelloun,
2017
2011 Morocco 4 zones Horse 840 - - 31.0 - - - - [74]
(Continued)
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Country City/governorate Species SS Prevalence (%) Ref
ELISA NT IF HI CF
IgM IgG cELISA
Durand, 2016 2012 Morocco Total Horse 349 - 60.0 - 74.0 - - - [67]
Agadir - 65.0 - - - -
Benslimane - 25.0 - - - -
Casablanca - 75.0 - - - -
Kenitra - 82.0 - - - -
Khenifra - 29.0 - - - -
Marrakech - 32.0 - - - -
Meknes - 34.0 - - - -
Salé - 50.0 - - - -
Sidi Slimane - 100 - - - -





Equine 449 - 65�0 - 55�4 - - - [75]
Azmi, 2017 2014 Palestine NA Equids 585 - - 75.0 - - - - [69]
DeCarlo, 2017 NA Qatar Throughout the country Horse 161 - - 27.0 - - - - [76]
Haroun, 2017 2006–
2014





Al-Ahsa Horse 63 - 33.3 - - - - [78]
Bargaoui, 2015 2009 Tunisia Jendouba, Monastir, Chott El Jerid,
Chott el Gharsa
Equine 1189 - 28.0 - - - - - [79]
Ben Hassine,
2014
2012 Tunisia Kebili Equine 284 - 45.2 - 42.3 - - - [80]
Wernery, 2007 NA UAE Total Equine 750 - - 19.2 - - - - [81]
Al Fujairah - 11.5




Al Ain - 12.0






Iran Mazandaran, Gilan, West Azerbaijan,
Tehran, Fars, Khuzestan
27 species NT+IF = 519;
RT-PCR = 400
- - - 15.0 - 0 [82]







154 - 0.7 - 0.7 - - -
Kébili oases 54 - 1.9 - 1.9 - - - [84]
Ayadi, 2017 2015 Tunisia Total Laughing
doves
226 - - 17.0 10 - - - [85]
Kettana 102 - - 23.0 15 - - -
Gafsa 53 - - 13.0 6.0 - - -
Degache 26 - - 4.0 4.0 - - -
Oum-Errous 45 - - 16.0 7.0 - - -
� 80% of ELISA positive samples were positive by NT.
Abbreviations: SS: Sample Size, ELISA: Enzyme-linked Immunosorbent Assay, cELISA: Competitive ELISA, NT: Neutralization Test, IF: Immunofluorescence Assay,
HI: Hemagglutination Inhibition Assay, CF: Complement Fixation, RT-PCR: Reverse Transcriptase-Polymerase Chain Reaction, NA: Data was not available, UAE:
United Arab Emirates.
https://doi.org/10.1371/journal.pntd.0007081.t003
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WNV prevalence in wild and domestic animals in the EMRO region
A total of 22 studies investigated the WNV seroprevalence in animals (Fig 2A and 2B). WNV
antibodies were detected in 10 countries, including, Djibouti (n = 1), Iran (n = 4), Jordan
(n = 1), Morocco (n = 4), Pakistan (n = 2), Palestine (n = 1), Qatar (n = 2), Saudi Arabia
(n = 1), Tunisia (n = 5) and the United Arab Emirates (UAE; n = 1). In these studies, serologi-
cal evidence of WNV infection was detected in a wide range of domestic and wild animals,
including Buffalos (Pakistan, total SS = 33, prevalence = 15.1%), Camels (Morocco, total
SS = 2775, prevalence = 8–23%; Palestine, total SS = 35, Prevalence = 40%; Tunisia, total
SS = 120, Prevalence = 0–25.8%), Cows (Pakistan, total SS = 45, prevalence = 2.2%), Goats and
sheep (Pakistan, total SS = 94, prevalence = 23.9%; Palestine, total SS = 95, prevalence = 14.7%),
Dogs (Djibouti, total SS = 91, prevalence = 56.5%; Morocco, total SS = 231, prevalence = 54–
96%), Ruminants (Djibouti, total SS = 11, prevalence = 25.3%), Equids (Iran, total SS = 1839,
prevalence = 0.8–70.3%; Jordan, total SS = 253, prevalence = 24.9%; Morocco, total SS = 1189,
prevalence = 25–100%; Pakistan, total SS = 449, prevalence = 65%; Palestine, total SS = 585,
prevalence = 75%; Qatar, total SS = 421, prevalence: 0–27%; Saudi Arabia, total SS = 63, preva-
lence = 33.5%; Tunisia, total SS = 1473, prevalence = 28.0–45.2%; the UAE, total SS = 750,
prevalence = 5.4–28.6%), and different types of wild and domestic birds (Iran, total SS = 519,
prevalence = 15%; Morocco, total SS = 346, prevalence = 3.5%; Tunisia, total SS = 434, preva-
lence = 0.7–23%). Table 3 provides further details on these studies.
Infection rate of vectors with WNV in the EMRO region
Nine studies investigated arthropods in order to analyze the WNV infection rate among vec-
tors. These reports were from Djibouti (n = 2), Egypt (n = 2), Iran (n = 2), Lebanon (n = 1),
Fig 3. Vector infection with the WNV in the EMRO region. From each study, only the names of vector species with evidence of WNV infection are written on the
map. Countries, from which the main vector for WNV (i.e., Cx. pipiens s.l.) was detected, are colored in orange. These countries include Djibouti, Egypt, Iran, and
Tunisia, all of which showed evidence of infection in the vector Cx. pipiens s.l.. Countries with no data on study on vectors are colored in gray. Among countries with
available data, only Lebanon had zero infection rates for all studied vector species.
https://doi.org/10.1371/journal.pntd.0007081.g003
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Pakistan (n = 1), and Tunisia (n = 1). The primary vector of WNV, i.e., Cx. pipiens s.l. [2], was
detected in Djibouti, Egypt, Iran, and Tunisia, and in all theses countries WNV infection in
Cx.pipiens s.l. was identified. WNV infection was also detected in a wide range of other vector
species, including Cx. quinquefasciatus (Djibouti), Ae. caspius (Iran), Cx. antennatus (Egypt),
Cx. perexiguus (Egypt), and Argas reflexus hermannii (Egypt). Details for studies on WNV
infection vectors are provided in Table 4 and Fig 3.
Discussion
Seroprevalence of WNV has been investigated in 14 of 22 countries in the EMRO region.
Since 1942, WNV antibodies have been detected in the general population in 11 countries with
available data, including: Djibouti, Egypt, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Paki-
stan, Sudan, and Tunisia. Our results also suggested that the overall seroprevalence of WNV
has been lower in reports from more recent years (since 2010) compared to reports compiled
between 1942 and 2009.
Although the presence of WNV infection remains unknown in countries without data in
the EMRO region (n = 14), it can be implied that the virus may probably circulate within these
countries as well. Existing evidence suggests cross-country dispersion of a number of viruses
such as human immunodeficiency virus (HIV) [91] and hepatitis B virus (HBV) [92]. These
observations can imply the hypothesis in which WNV also have dispersed across countries in
the region, affecting localities (countries) adjacent to infected areas. The argument is further
strengthened if we consider the transmission routes of HIV, HBV, and WNV. The transmis-
sion of HIV and HBV depends on effective human-to-human contacts, which acts as a barrier
for virus dispersion over large geographic distances. However, similar to other arboviruses like
Dengue and Crimean-Congo Hemorrhagic Fever [93, 94], the cross-country spread of WNV
can be much easier and fast as it can be transmitted through a broad range of vectors and
reservoirs.
Most of the seroepidemiological studies included in this review used ELISA for the detec-
tion of anti-WNV antibodies. Although this assay is simple, sensitive, and commercially
available, it suffers from cross-reactivity with antibodies raised against other flaviviruses.
So, using the ELISA method for testing individuals with a history of vaccination against, or
infection with related flaviviruses can yield false positive results [95]. To achieve a more spe-
cific measurement, positive ELISA test results should be confirmed by the plaque reduction
neutralization test (PRNT), which is considered as the gold standard method for WNV
serological testing. However, PRNT can detect antibodies at levels that neutralize the virus;
therefore, it has low sensitivity for seroepidemiological studies in weakly-exposed popula-
tions [95].
Approximately, one-fifth of WNV infected individuals demonstrate symptomatic infection
[96]. Clinical symptoms are also non-specific to the disease and include fever, malaise, head-
ache, back pain, myalgia, and anorexia. Therefore, WNV infected individuals can be misdiag-
nosed with other febrile infections. In areas with evidence of WNV circulation, WNV
infection should be considered as a differential diagnosis for patients demonstrating non-dif-
ferential febrile syndroms.
Non-specific sympotoms of the WNV infection also highlights the need for laboratory test-
ing of suspected human cases. While WNV IgM is the most common target for confirmation
of the infection, viral RNA testing can also be performed. Combining IgM detection and viral
RNA testing can enhance the possibility of diagnosis in patints with West Nile fever, as indi-
cated by Tilley et al. [97]. However, among 15 studies on patient populations, only four used a
combination of serological and molecular assays for the diagnosis of WNV infection.
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In this review, we have highlighted serological evidence of WNV infection from 22 inde-
pendent studies conducted on animal populations in the region. These studies were carried
out in 10 countries including, Djibouti, Iran, Jordan, Morocco, Pakistan, Palestine, Qatar,
Saudi Arabia, Tunisia, and the UAE. Most studies, have investigated evidence of WNV infec-
tion among domestic animals. Since 2010, the highest prevalence of WNV among domestic
animals, has been reported among dogs of Morocco and equids of Morocco, Pakistan, Pales-
tine and Iran. The high rates of animal seropositivity and geographic distribution of animal
infection reflect the favorable conditions for the circulation of WNV in these countries. In
these areas, stronger preventive measures should be considered to reduce the risk of WNV
transmission to humans and horses. High seropositivity among dogs and equids also suggests
that these animals can be useful sentinels for WNV surveillance, as discussed by previous stud-
ies [98–100]. Resnick, et al. (2008) reported that WNV seroconversion in dogs happened six
weeks prior to the infection in exposed human cases [100].
Only two studies from Pakistan (on rodents) [45] and Djibouti (on wild ruminants) [66])
have investigated wild animals’ infection with WNV. The paucity of published studies on the
prevalence of WNV infection in wild animals of the EMRO region underlines a gap in current
knowledge about the issue. Knowledge about the reservoirs’ infection and virus circulation
among wild animals has important implications for forecasting the emergence or re-emer-
gence of WNV epidemics[95]. So, it is recommended future seroprevalence studies include
representative samples from wild animals to further illuminate the state of the infection
among these hosts.
Four studies investigated the infection among birds from Iran, Morocco, and Tunisia, from
which only two studies were recently performed (i.e., Tunisia, 2015 and 2017). These observa-
tions also highlight a gap in current knowledge, this time, on the extend of the infection
among birds of the EMRO region. Birds play a critical role in the maintenance and spread of
the virus. Prolonged high levels of viremia have been demonstrated in several bird species
[101, 102]. The virus has also been isolated from several migratory birds. Thus, surveillance of
WNV infection among birds would be of great importance, especially in areas with favorable
ecological conditions for birds and mosquitoes. In this regards, a better understanding of birds
migration routes would be helpful in selecting the most probable sites for tracking the virus
[102], and subsequently making judgments on what areas might be focal points for the emer-
gence of WNV outbreaks.
Mosquitoes and birds are currently considered to have the key role in the life cycle of the
virus [2]. However, there are more than 30 other vertebrates such as lemurs, frogs, hamsters,
squirrels, rabbits, and chipmunks that have been reported as possible reservoirs for the virus,
since they can provide viremia levels that are sufficient to infect mosquito vectors [103]. The
role of these reservoirs in the WNV life cycle and epidemic has been less regarded till now, and
is an open area for future research.
Despite the critical role of the vector in the life cycle and the epidemic of WNV, only
nine studies have investigated vector infection in the region. These studies have been con-
ducted in Djibouti, Egypt, Iran, Pakistan, and Tunisia. The primary vector of WNV, i.e., Cx.
pipiens s.l. [2] was detected in all investigared countries except Pakistan. Although WNV
infection has been detected in more than 60 mosquito species, detection of viral infection in
a mosquito alone does not indicate that the mosquito is a competent vector for the virus. In
addition to Culex species, WNV has also been detected in Aedes and Mansonia mosquitoes.
Additional studies are necessary to further clarify the potential role these species in the
maintenance and transmission of WNV. Interestingly, WNV infection was observed in
ticks Argas reflexus hermannii. Previous studies from other regions of WHO also detected
WNV RNA in ticks R. turanicus and mites D. gallinae and O. sylvarum. However, their
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competency as vectors is less clear [104]. Reducing virus transmission from a vector is one
of the main strategies of controlling arboviral diseases. Therefore, more efforts to identify
the main vectors and understand virus–vector interaction in burdened countries would
benefit disease control strategies [105].
The main limitations of this systematic review relate to the data. First, there is a paucity of
prevalence studies in the EMRO region, and the quality of data reported by studies varied. For
instance, many available studies on human populations were focused on adults, or did not
report age and gender for the study sample. The remaining studies included a broad range of
age groups (including infant, children, and adults), most of which did not report age and gen-
der specific prevalence. Prevalence data on healthy infants and young children alone was par-
ticularly sparse. Therefore, the state of the epidemic among different age and sex groups
remains unknown in this region and requires further study with representative samples.
Although current data provides a good basis for an overall judgment about the presence of cur-
rent/past WNV exposure in most investigated samples, they can hardly be used to infer the
actual prevalence and state of the epidemic in most investigated countries. For example, only
in four countries with available data on the ‘general population’ (i.e., Egypt, Iran, Lebanon,
and Pakistan), the total number of tested individuals was reasonably representative of the tar-
get population (i.e., more than 1000). These ‘powerful’ studies, however, were not totally flaw-
less. One of the main limitations of these studies was that some of them had used convenience
(non-random) sampling methods. In convenience sampling, individuals have unequal and
unknown probability of being selected [106]. Hence, the resulting seroprevalence estimates
should be generalized to the target population with caution. Few studies available from animal
populations in the region also suffered from the abovementioned shortcomings; i.e., non-ran-
dom sampling and small sample sizes. For example, the seroprevalence of WNV has been
investigated in Morocco, Palestine, and Tunisia, but only the study in Morocco has provided
the estimate based on a fairly representative sample of 556 and 836 camels for the years 2003
and 2009, respectively. The case was even worse for the seroprevalence studies on dogs, cows,
sheep, goats, buffalos, and birds as none of the available studies were well-powered enough (i.
e., had small sample sizes). The situation was more satisfactory for the population of horses,
where a number of studies with large sample sizes were available from different parts of Iran,
Morocco, Pakistan, Palestine, Tunisia, and the UAE. Second, the relative dearth of recent sero-
prevalence studies, particularly from burdened areas for WNV infection and high-risk popula-
tion groups is a serious limitation. As the face of WNV disease and its geographic range
changes rapidly, WNV prevalence estimated by older studies may not properly reflect the cur-
rent status of WNV circulation. Less accurate serological tests used by older studies also affect
the validity and reliability of the prevalence estimates in these studies. Standardized seropreva-
lence studies at national levels are critical to best appraise the epidemic status, the impact of
interventions and the potentials for future outbreaks. Third, substantial within-country het-
erogeneity in the prevalence of WNV was noted. This might be due to diversity in the geo-
graphical areas, target groups, and the reported sample sizes of studies. Local prevalence
estimates, hence, might not be representative of national level prevalence, particularly in large
countries with much geographic and ethnic disparities. Finally, our review is limited to reports
written in English.
Conclusions
This review provides estimates of the scale of the WNV epidemic at country and regional levels
in order to inform efforts for developing and implementing effective future responses. Our
results suggested the circulation of WNV in humns, animals, or vectors of most investigated
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countries in the region. However, there is paucity of data about WNV infection, especially
with respect to the burden of the infection in most countries across the region. Hence, further
epidemiological studies that take into account the human, reservoir and vector dimension/
aspect of the occurrence and distribution of the virus should be conducted particularly in
high-prevalent countries. Such research effort will generate robust knowledge and a detailed
understanding of the epidemiology of the infection in local populations, and foster in-depth
investigations about transmission patterns of the virus. Identification of the geographic distri-
bution of primary reservoirs of the virus and their infection status can also enhance targeted
prevention and elimination efforts and aid forecasting attempts. Moreover, surveillance capac-
ities in EMRO countries ought to be established or expanded for better monitoring of WNV
infection at national and regional levels.
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